Mut12, an α-amylase mutant of Aspergillus oryzae, its construction method and application

By constructing the Aspergillus oryzae α-amylase mutant Mut12, the problem of insufficient thermal stability of Aspergillus oryzae α-amylase was solved, and the stability and catalytic activity under high temperature conditions were improved, making it suitable for starch hydrolysis and maltodextrin preparation.

CN123107967APending Publication Date: 2026-11-17HENAN UNIVERSITY OF TECHNOLOGY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611461222.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-20
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

The existing Aspergillus oryzae α-amylase has poor thermal stability, which limits its application in high-temperature industries. Furthermore, multi-site combined mutations often lead to negative epistatic effects, making it difficult to simultaneously improve thermal stability and catalytic activity.

Method used

Random mutant libraries were constructed using error-prone PCR. Combined with high-throughput screening and combinatorial and reverse mutation optimization, the Aspergillus oryzae α-amylase mutant Mut12 was obtained, which contains 12 amino acid substitutions, improving thermal stability while maintaining catalytic activity.

Benefits of technology

The optimal reaction temperature of mutant Mut12 is increased to 72℃, the half-life is extended by about 4 times at 65℃, and the catalytic activity is increased by about 20%, making it suitable for high-temperature industrial processes such as starch hydrolysis and malt oligosaccharide preparation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123107967A_ABST
    Figure CN123107967A_ABST
Patent Text Reader

Abstract

This invention discloses a *Aspergillus oryzae* α-amylase mutant Mut12, its construction method, and its applications, belonging to the fields of genetic engineering and enzyme engineering technology. The mutant is a truncated α-amylase. To the AmyB1 serves as the parent enzyme, containing 12 amino acid substitutions: A4P, G56A, T72I, H122R, K180R, Q212R, K221R, S264L, N277S, A302T, A315V, and Q333H. This invention utilizes error-prone PCR to construct a random mutant library and employs high-throughput screening to obtain beneficial mutation sites. Through combination and reverse mutation optimization, the negative epistatic effect caused by multiple site superposition is overcome, resulting in the mutant Mut12 with significantly improved thermostability. Compared to the parent enzyme, Mut12 exhibits an optimal reaction temperature increased from 55℃ to 72℃, a half-life extended by approximately four times at 65℃, and maintains high catalytic activity. This invention provides a novel enzyme molecule resource and an effective technical approach for the thermostability modification of industrial α-amylases.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the fields of genetic engineering and enzyme engineering technology, specifically relating to a mutant Aspergillus oryzae α-amylase Mut12, its construction method, and its application. Background Technology

[0002] α-Amylases are a class of endonucleases that randomly hydrolyze the α-1,4 glycosidic bonds within starch and related α-glucans. They are widely used in starch sugar production, baking, brewing, fermentation, and animal feed industries. They are derived from *Aspergillus oryzae* (…). Aspergillus oryzae α-Amylases from *Aspergillus oryzae* have significant applications in food processing due to their good food safety (GRAS certification) and suitable catalytic properties. However, fungal α-amylases generally suffer from poor thermal stability, easily undergoing conformational changes at high temperatures leading to irreversible inactivation. This limits their application in processes such as high-temperature starch liquefaction, spray cooking, and continuous hydrolysis. Therefore, improving the thermal stability of *Aspergillus oryzae* α-amylase while maintaining its good catalytic performance is an important research direction for expanding its industrial applications.

[0003] Various strategies have been reported for molecularly modifying the thermostability of α-amylases, including site-directed mutagenesis, directed evolution, and rational design. Researchers have achieved improved thermostability in α-amylases from multiple sources by introducing disulfide bonds, increasing surface charge interactions, optimizing hydrophobic cores, and enhancing rigidity. However, a "stability-activity trade-off" often exists between thermostability and catalytic activity; that is, improving thermostability often results in a decrease in catalytic efficiency. Therefore, maintaining or even improving catalytic activity while enhancing thermostability remains a significant challenge in this field.

[0004] It is worth noting that a simple combination of multiple beneficial mutations does not necessarily produce the expected cumulative effect. As the number of combined mutations increases, complex epistasis may occur between different mutation sites through spatial conformational rearrangements, local interaction network reconstruction, and long-range dynamic coupling, leading to performance deviations from theoretical expectations in the combined mutants. Negative epistasis can even cause the combination of multiple beneficial mutations in a single-site context to exhibit performance lower than that of the parent enzyme. In recent years, protein evolution research has consistently demonstrated that epistasis is widespread in protein functional evolution and enzyme engineering optimization, becoming a significant bottleneck limiting the rational design of multi-site combinations. Therefore, effectively identifying and avoiding negative epistasis in a multi-site combination context is a key technical challenge for achieving synergistic improvement in enzyme molecular performance.

[0005] Currently, there is a lack of successful examples of methods that can effectively integrate multiple beneficial mutations into Aspergillus oryzae α-amylase, synergistically enhance thermal stability, and maintain high catalytic activity. To address these issues, this invention utilizes a truncated form of Aspergillus oryzae α-amylase. Ao Using AmyB1 as the starting enzyme, a random mutant library was constructed through error-prone PCR and multiple beneficial mutation sites were obtained through high-throughput screening. Furthermore, through a combination and reverse mutation optimization strategy, a combined mutant Mut12 with significantly improved thermal stability and high catalytic activity was successfully obtained, providing a new enzyme molecule resource and an effective technical approach for the thermal stability modification of industrial α-amylase. Summary of the Invention

[0006] This invention discloses a mutant Aspergillus oryzae α-amylase, Mut12, its construction method, and its applications. The mutant is a truncated α-amylase. Ao AmyB1 is the parent, containing 12 amino acid substitutions. This invention utilizes error-prone PCR to construct a random mutant library combined with high-throughput screening to obtain beneficial mutation sites. Through combination and reverse mutation optimization, the negative epistatic effect caused by multiple site superposition is overcome. Compared to the parent, Mut12 exhibits an optimal reaction temperature increased from 55℃ to 72℃, and a half-life extended by approximately four times at 65℃, while maintaining high catalytic activity. It is suitable for high-temperature industrial catalytic processes such as starch hydrolysis, starch sugar production, and maltodextrin preparation.

[0007] On the one hand, the present invention provides an Aspergillus oryzae α-amylase mutant, which adopts the following technical solution: A mutant of Aspergillus oryzae α-amylase, the amino acid sequence of which is shown in SEQ ID NO:16.

[0008] Preferably, the mutant is designated by SEQ ID. Based on the amino acid sequence of the truncated form of Aspergillus oryzae α-amylase AoAmyB~1~ shown in NO:8, it contains the following 12 amino acid substitutions: alanine at position 4 is mutated to proline (A4P), glycine at position 56 is mutated to alanine (G56A), threonine at position 72 is mutated to isoleucine (T72I), histidine at position 122 is mutated to arginine (H122R), lysine at position 180 is mutated to arginine (K180R), glutamine at position 212 is mutated to arginine (Q212R), lysine at position 221 is mutated to arginine (K221R), serine at position 264 is mutated to leucine (S264L), asparagine at position 277 is mutated to serine (N277S), alanine at position 302 is mutated to threonine (A302T), alanine at position 315 is mutated to valine (A315V), and glutamine at position 333 is mutated to histidine (Q333H).

[0009] This invention also provides a DNA molecule encoding an Aspergillus oryzae α-amylase mutant, using the following technical solution: A DNA molecule encoding an Aspergillus oryzae α-amylase mutant, the nucleotide sequence of which is shown in SEQ ID NO:15.

[0010] The present invention also provides a recombinant expression vector containing the above-described DNA molecule.

[0011] On the other hand, the present invention also provides a method for constructing an Aspergillus oryzae α-amylase mutant, which adopts the following technical solution: A method for constructing an α-amylase mutant of Aspergillus oryzae includes the following steps: (1) Using the AoAmyB1 gene, a truncated form of Aspergillus oryzae α-amylase shown in SEQ ID NO:7, as a template, a random mutant library was constructed by error-prone PCR; (2) Perform high-throughput screening on the random mutant library obtained in step (1) to obtain positive clones with improved thermal stability; (3) Sequencing of positive clones to identify beneficial mutation sites; (4) Combine multiple beneficial mutation sites obtained from screening to construct a combined mutant; (5) Perform reverse mutation optimization on the combined mutants obtained in step (4) and screen to obtain mutants with improved thermal stability.

[0012] Preferably, in step (2), the high-throughput screening uses the residual enzyme activity after treatment at 68°C for 30 min as the screening index.

[0013] Preferably, the combined mutant in step (4) is Mut14 containing 14 amino acid substitutions, the 14 amino acid substitutions being: A4P, G56A, T72I, A120T, H122R, C150S, K180R, Q212R, K221R, S264L, N277S, A302T, A315V, and Q333H.

[0014] Preferably, the reverse mutation optimization in step (5) includes: removing the two mutation sites A120T and C150S from Mut14 to obtain Mut12 containing 12 amino acid substitutions.

[0015] This invention also provides an application of Aspergillus oryzae α-amylase mutant in starch hydrolysis or malt oligosaccharide preparation.

[0016] In summary, the beneficial effects of the present invention are as follows: The mutant Mut12 obtained by this invention has an optimal reaction temperature that is increased from 55℃ to 72℃, a half-life that is extended by about 4 times at 65℃, a specific activity that is increased by about 20%, and an optimal pH of 5.5, maintaining a wide pH adaptation range. It also has excellent catalytic stability under high temperature conditions, overcoming the technical problem of traditional α-amylases that are difficult to balance thermal stability and catalytic activity.

[0017] This invention effectively integrates multiple beneficial mutation sites through random mutant library construction combined with high-throughput screening. Furthermore, by employing a combination and reverse mutation optimization strategy, it successfully avoids the negative epistatic effect in multi-site combinations, providing a new technical approach for modifying the thermostability of industrial enzymes. The mutants obtained by this invention are suitable for high-temperature industrial catalytic processes such as starch hydrolysis, starch sugar production, and malt oligosaccharide preparation, and have broad industrial application prospects. Attached Figure Description

[0018] Figure 1 Results of random mutation library screening; Figure 2 Performance analysis of the reverse mutant in this invention; in, Figure 2 In the middle, 'a' represents the optimal temperature and catalytic activity analysis of the first-round reversion mutant; Figure 2 In Figure b, the optimal temperature and catalytic activity analysis of the second-round reversion mutant are presented. In both a and b, the maximum activity of WT is defined as 100%, and the activities of all variants at different temperatures are normalized relative to this value. Figure 3 Thermal stability analysis of WT, Mut14 and Mut12; Figure 4 Characterization of the enzymatic properties of Mut12 in this invention; in, Figure 4 In this context, 'a' represents the optimal reaction temperature for Mut12. Figure 4 In this context, b represents the optimal reaction pH for Mut12. Figure 4 In this context, 'c' represents the thermal stability of Mut12. Figure 4 In the middle, d represents the SDS-PAGE analysis of Mut12 expression purification; Figure 4 In the image, e represents the thin-layer chromatography (TLC) hydrolysis products of WT and Mut12; Figure 5 Application of Mut12 in corn starch hydrolysis; in, Figure 5 In the figure, 'a' represents the hydrolysis conversion rate of corn starch by WT and Mut12.

[0019] Figure 5b represents the quantitative analysis of the hydrolysis products of WT and Mut12. Detailed Implementation

[0020] The present invention will be further described in detail below with reference to the embodiments.

[0021] Example 1 Aspergillus oryzae α-amylase truncated form Ao The specific steps for obtaining AmyB1 and constructing its expression vector are as follows: 1. Total length Ao Acquisition of the Amy gene Aspergillus oryzae ( Aspergillus oryzae Using genomic DNA as a template, the full-length gene of Aspergillus oryzae α-amylase was amplified by PCR. Ao Amy designed amplification primers based on the Aspergillus oryzae α-amylase gene sequence reported in GenBank (GenBank accession number: D00434.1).

[0022] Primers for full-length gene amplification: AoAmy-F (SEQ ID NO: 2): 5′-ATGGTGGCTTGGTGGTCTCTATTTCTGTAC-3′ AoAmy-R (SEQ ID NO: 3): 5′-CTACAAAGCTGCAAGAGCTTCAGCTTCT-3′ The PCR reaction system and conditions were performed according to standard methods. The PCR products were purified by agarose gel electrophoresis and then sequenced for verification; the obtained sequences were consistent with previously reported sequences.

[0023] 2. Truncated body Ao Acquisition of the AmyB1 gene according to Ao Based on the full-length gene sequence of Amy (SEQ ID NO:1) and the domain information of its encoded protein (SEQ ID NO:4), the 119 amino acid residues corresponding to its C-terminal sugar-binding domain (CBM) were determined. By deleting these 119 amino acid residues corresponding to the C-terminal domain, a truncated α-amylase was obtained. Ao For AmyB~1~, the following specific primers were designed for PCR amplification: Truncated amplification primers: Ao AmyB~1~-F:5′-GAATTCGCTACACCTGCTGACTGG-3′(containing EcoR I restriction site, underlined part)(SEQ ID NO: 5) AoAmyB~1~-R:5′-GCGGCCGCTCAAGAAGATGA-3′(Contains Not I restriction site and stop codon, underlined part)(SEQ ID NO: 6) upstream primer Ao AmyB~1~-F corresponds to Ao Nucleotides 1-18 of the 5′ end of the Amy gene (excluding the signal peptide coding sequence). Downstream primer Ao AmyB~1~-R corresponds to the 3′ end sequence of the truncated gene. This primer is designed so that the amplification product retains only the coding sequence of the N-terminal catalytic domain, and the stop codon TGA is introduced to ensure that translation terminates accurately at the truncated position.

[0024] With the correct full-length sequence Ao Using the Amy gene as a template, PCR amplification was performed using the primers described above. The PCR reaction system (50 μL) is shown in Table 1.

[0025] Table 1. Truncated body Ao AmyB~1~ gene PCR amplification reaction system

[0026] PCR amplification program: 95℃ pre-denaturation for 3 min; 98℃ denaturation for 10 s, 55℃ annealing for 15 s, 72℃ extension for 1 min, for a total of 30 cycles; 72℃ final extension for 10 min.

[0027] The PCR product was identified by 1.0% agarose gel electrophoresis, and a specific amplified band was visible at approximately 1.2 kb. The target fragment was purified and recovered using a gel extraction kit to obtain the desired product. Ao The truncated AmyB1 gene fragment (SEQ ID NO: 7) has the amino acid sequence SEQ ID NO: 8.

[0028] 3. Recombinant expression plasmid pPIC9K- Ao Construction of AmyB1 The above purified Ao The AmyB1 gene fragment and the Pichia pastoris secretory expression vector pPIC9K were double-digested with restriction endonucleases EcoRI and NotI, respectively. The digestion reaction volume (50 μL) is shown in Table 2.

[0029] Table 2 Ao AmyB1 gene fragment and pPIC9K vector double enzyme digestion reaction system

[0030] The enzyme digestion reaction was carried out at 37℃ for 3 h. The digestion products were separated by agarose gel electrophoresis, and the digested target gene fragment and linearized vector fragment were recovered separately. The double-digested DNA fragments were then ligated using T4 DNA ligase. Ao The AmyB1 gene fragment was mixed with the linearized pPIC9K vector at a molar ratio of 3:1 and ligated overnight at 16°C. The ligation reaction volume (10 μL) is shown in Table 3.

[0031] Table 3 Ao AmyB1 gene fragment ligation reaction system with linearized pPIC9K vector

[0032] 4. Transformation of recombinant plasmids into E. coli and screening of positive clones. Transform 10 μL of the ligation product into E. coli DH5α competent cells, incubate on ice for 30 min, then heat shock at 42℃ for 90 s, immediately incubate on ice for 2 min, add 900 μL of LB liquid medium, and resuscitate at 37℃ and 200 rpm for 1 h. Spread an appropriate amount of the resuscitated bacterial culture onto LB agar plates containing 50 μg / mL kanamycin, and incubate upside down at 37℃ overnight.

[0033] Single colonies grown on the plate were inoculated into LB broth containing kanamycin and incubated overnight at 37°C with shaking. Plasmids were then extracted. The extracted plasmids were verified by double digestion with EcoRI and NotI. A correct recombinant plasmid should yield approximately 1.2 kb of the target gene fragment. The correctly digested recombinant plasmids were then sent for sequencing to further confirm the target gene sequence. Ao The AmyB~1~ sequence is completely identical to the theoretical sequence and maintains the correct reading frame fusion with the α-factor signal peptide coding sequence on the vector. The correctly sequenced recombinant plasmid was named pPIC9K- Ao AmyB~1~.

[0034] 5. Recombinant plasmid transformation of Pichia pastoris SMD1168 Take 10 μg of recombinant plasmid pPIC9K- Ao AmyB1 was linearized by single-enzyme digestion with the restriction endonuclease Sal I, and the digestion reaction was carried out overnight at 37°C. The digestion product was purified by ethanol precipitation and then dissolved in 10 μL of sterile ddH2O for later use.

[0035] Preparation of Pichia pastoris SMD1168 electrocompetent cells: Fresh single colonies were picked and inoculated into 5 mL of YPD liquid medium and cultured overnight at 30°C and 200 rpm; the next day, they were transferred to 100 mL of YPD medium and cultured until OD500. 600The bacterial culture was prepared at a concentration of 1.3–1.5. After incubating on ice for 15 min, the bacterial cells were collected by centrifugation at 4°C. The bacterial cells were washed twice each with pre-cooled sterile water and 1 M sorbitol solution. Finally, the bacterial cells were resuspended in 1–2 mL of pre-cooled 1 M sorbitol solution, aliquoted into 80 μL tubes, and stored at -80°C for later use.

[0036] Take 80 μL of the above competent cells, add 5 μL of linearized recombinant plasmid DNA (approximately 5 μg), mix gently, and transfer to a pre-chilled 0.2 cm electroporation cuvette. Incubate on ice for 5 min. Perform electroporation transformation using an electroporator at 1500 V, 200 Ω, and 25 μF. Immediately after electroporation, add 1 mL of pre-chilled 1 M sorbitol solution, transfer the bacterial culture to a centrifuge tube, and incubate at 30°C for 2 h. Spread 200 μL of the revived bacterial culture onto an MD plate and incubate upside down at 30°C for 2–4 days until transformants appear.

[0037] 6. Screening and identification of positive transformants Transformants grown on MD plates were picked and seeded onto YPD plates containing different concentrations of G418 (0.5, 1.0, and 2.0 mg / mL). They were incubated at 30°C for 2–3 days to screen for high-copy-count integrated transformants. Genomic DNA was extracted from G418-resistant transformants and used as templates, along with primers... Ao AmyB1-F and Ao PCR amplification was performed using AmyB1-R to verify the correct integration of the target gene into the Pichia pastoris genome. Simultaneously, SMD1168 strain transformed with the empty vector pPIC9K served as a negative control. The correctly identified positive transformant was named SMD1168 / pPIC9K- Ao AmyB1, store in glycerol at -80℃ for later use.

[0038] Example 2 The specific steps for constructing and screening random mutation libraries are as follows: Design primers containing homologous arms (underlined portions). Ao AmyB1-F: 5' GAGAGGCTGAAGCTTACGTA GAATTCGCTACACCTGCTGAC3' (SEQ ID NO: 9) and Ao AmyB1-R: 5' ATGTCTAAGGCGAATTAATTC GCGGCCGCTCAAGAAGATGA3'. (SEQ ID NO: 10) Using the Gene Morph II random mutagenesis kit purchased from Agilent Technologies, the pPIC9K- was used according to the kit instructions. Ao AmyB1 was used as a template for α-amylase. AoError-prone PCR was performed on the AmyB1 gene. After amplification, randomly mutated gene fragments were recovered using a gel extraction kit. The gene fragments and plasmids were ligated using a one-step cloning method. Primers pPIC9K-F: 5'GAATTAATTCGCCTTAGACATGACTG 3' (SEQ ID NO: 11) and pPIC9K-R: 5'TACGTAAGCTTCAGCCTCTCT 3' (SEQ ID NO: 12) were designed to ligate the gene fragments and plasmids. Ao Using AmyB1 as a template, a linear pPIC9K fragment with EcoRI and NotI restriction sites at both ends was amplified. The randomly mutated α-amylase was then cloned using the Bomeid Seamless Cloning Kit. Ao The AmyB1 gene fragment was ligated to the amplified long fragment. The ligation product was recovered using a gel extraction kit. The successfully ligated recombinant plasmid was transformed into prepared E. coli DH5α competent cells, and the bacterial culture was plated on LB agar plates containing antibiotic (Kana) and incubated overnight at 37°C. The number of colonies grown on the antibiotic plates was roughly estimated. The transformed individuals were washed off with LB liquid medium, incubated at 37°C and 200 rpm for 3 h, and then the plasmid was extracted, thus completing the construction of the random mutant library. Transformants were picked and cultured in 96-well plates to induce expression. The residual enzyme activity after treatment at 68°C for 30 min was used as a screening index for high-throughput screening of the mutant library.

[0039] Establishment of high-throughput screening system: 96-well plate reaction detection system: 200 μL of BMGY medium was added to a 96-well plate, and wild-type strains were picked into the 96-well plate and cultured at 28°C and 200 rpm for 2 days; after centrifugation and discarding the supernatant, the bacterial cells were resuspended in 150 μL of BMGY medium and cultured at 28°C and 200 rpm for 5 days, with 1% methanol added daily; after centrifugation, the supernatant was collected. Enzyme activity assay: 50 μL of bacterial culture was transferred to a new 96-well plate. Two 96-well plates were labeled as the control group and the experimental group, respectively. The experimental group bacterial culture was treated at 60°C, 65°C, 68°C, and 70°C for 15 min, 30 min, and 45 min, respectively, and then cooled in a 4°C refrigerator. Then, 50 µL of 10 mM CNPG3 solution (dissolved in 50 mM phosphate buffer, pH 6) was added to both the control and experimental group 96-well plates. The reaction was carried out at 40°C for 10 min, and then 100 µL of 0.5 M Na2CO3 was added to terminate the reaction. The OD value at 405 nm was measured. The optimal treatment temperature and time for the high-throughput screening system were determined based on the residual enzyme activity of the experimental group. After confirming the conditions, the signal-to-noise ratio and coefficient of variation of the system were calculated to verify its stability.

[0040] Example 3 The specific steps for obtaining beneficial mutation sites are as follows: A mutant library with an amino acid mutation rate of 0.45% was constructed using directed evolution. To screen for mutants, over 8000 clones were cultured and enzyme production was induced. After treatment at 68℃ for 30 min, 13 strains with residual enzyme activity more than 1.5 times higher than the WT were obtained through screening and verification. Figure 1 Sequencing results showed that the 13 positive clones contained a total of 16 amino acid substitutions, of which 3 strains contained two amino acid mutation sites, and the rest contained one amino acid mutation (Table 4). Double mutation splitting and single-point reconstruction validation showed that K209I and K280R did not exhibit significant improvements in thermostability, and 14 candidate mutation sites with positive effects were obtained (A4P, G56A, T72I, A120T, H122R, C150S, K180R, Q212R, K221R, S264L, N277S, A302T, A315V, Q333H). Table 4 Candidate strains

[0041] Example 4 The construction of the combined mutant Mut14 follows these steps: To further evaluate the combined effects of multiple beneficial mutations, the 14 candidate advantageous mutation sites were combined and integrated into the gene through gene synthesis. Ao The AmyB1 coding sequence was used to construct the combinatorial mutant Mut14. Compared with WT, the overall performance of mutant Mut14 did not show a sustained improvement, and its enzyme activity and thermostability were significantly lower than those of WT. Figure 2 Although each mutation is beneficial in the WT context, their combination results in a cumulative effect of multiple mutations that is far less than theoretically expected.

[0042] DNA sequence of mutant Mut14 (SEQ ID NO: 13): GCTACACCT CCT GACTGGAGAAGTCAATCCATCTACTTTCTGTTGACCGATAGATTCGCTAGAACTGATGGTTCCACTACCGCTACATGTAACACCGCTGATCAGAAGTATTGCGGTGGAACTTGGCAAGGCATCATCGACAAACTGGACTATATCCAAGGTATG GCT TTCACTGCTATCTGGATTACACCTGTTACTGCACAATTGCCTCAA ATCACTGCTTATGGTGATGCTTATCATGGTTACTGGCAGCAAGACATCTACTCTCTGAATGAGAACTACGGTACTGCTGACGATCTGAAAGCCTTGTCTAGTGCCTTGCATGAAAGAGGTATGTATCTGATGGTTGATGTCGTT ACT AAT CGC ATGGGATACGATGGTGCTGGATCTTCTGTTGATTATAGTGTGTTCAAGCCTTTCTCTAGTCAAGATTATTTCCATCCATTC TCT TTCATCCAGAACTACGAGGATCAAACTCAAGTCGAAGATTGCTGGTTGGGAGATAATACCGTCTCTTTGCCAGACTTGGACACCACA AGG GATGTCGTTAAGAACGAATGGTACGATTGGGTTGGTTCACTGGTTTCCAATTACTCTATTGATGGACTGAGAATTGATACTGTCAAACATGTT CGG AAAGATTTCTGGCCTGGCTACAAC AGG GCTGCCGGTGTCTACTGTATTGGTGAAGTGTTGGATGGCGACCCTGCATACACTTGTCCATATCAGAACGTCATGGACGGAGTCTTGAACTATCCAATCTACTATCCATTGCTGAATGCTTTCAAG CTT ACTTCTGGCTCAATGGATGATCTGTACAACATGATC AGC ACCGTTAAGTCTGATTGTCCAGATTCCACTTTGTTGGGTACTTTCGTTGAGAACCATGACAATCCAAGATTC ACT TCTTACACTAATGACATCGCTCTGGCTAAGAACGTT GTT GCTTTCATCATCTTGAACGATGGTATTCCAATCATCTACGCTGGTCAAGAA CAC CATTATGCTGGTGGTAATGATCCAGCTAATAGAGAGGCTACTTGGCTGTCTGGTTATCCAACCGATTCTGAGCTGTAC The amino acid sequence of mutant Mut14 (SEQ ID NO: 14): ATPPDWRSQSIYFLLTDRFARTDGSTTATCNTADQKYCGGTWQGIIDKLDYIQGMAFTAIWITPVTAQLPQITAYGDAYHGYWQQDIYSLNENYGTADDLKALSSALHERGMYLMVDVVTNRMGYDGAGSSVDYSVFKPFSSQDYFHPFSFIQNYEDQTQVEDCWLGDNTVSLPDLDTT RDVVKNEWYDWVGSLVSNYSIDGLRIDTVKHVRKDFWPGYNRAAGVYCIGEVLDGDPAYTCPYQNVMDGVLNYPIYYPLLNAFKLTSGSMDDLYNMISTVKSDCPDSTLLGTFVENHDNPRFTSYTNDIALAKNVVAFIILNDGIPIIYAGQEHHYAGGNDPANREATWLSGYPTDSELY Example 5 The specific steps for screening the optimal mutant in response to mutations are as follows: The structure and computation of 14 beneficial mutations were evaluated in the Mut14 context. FoldX was used to assess the potential destabilizing effects of a single mutation in the Mut14 structural context (Table 5). Spatial distances between two mutation sites and distances from mutation sites to the active site were calculated using protein structure analysis (Table 6). B-factor flexibility and mutation type diversity analyses were also performed (Table 5). Based on predicted instability trends, spatial clustering, proximity to functional regions, and local structural environment, six mutations were prioritized as T72I > Q212R > K221R > A120T > S264L > C150S for experimental recovery. Under the applied criteria, the remaining mutations showed lower predicted recovery priority and were therefore retained in the initial design. Based on this prioritization, six single-point recovery knockout mutants (R1-1 to R1-6) were constructed against a fully synthetic mutant background. Enzymatic properties of WT, Mut14, and each mutant were analyzed. All six candidate revertants showed some degree of functional recovery, but the degree of recovery did not completely align with the calculated predicted priority. R1-4 (reverting to A120T) produced the most significant high-temperature activity recovery, indicating a discrepancy between the predicted and experimental results. Therefore, further experimental screening was conducted to identify key reverting sites. To rule out the possibility that the strong negative effect of A120T might mask the true role of other sites, the actual contributions of K221R, S264L, and C150S under this optimal background were further investigated. Therefore, R1-4 was selected as the second-round reverting background, and three secondary reverting mutants were constructed: R2-1 (reverting to K221R), R2-2 (reverting to S264L), and R2-3 (reverting to C150S). Enzymatic analysis was performed on the secondary mutants. Results are shown below. Figure 2 Compared with R1-4, R2-1 showed no significant difference in optimal temperature and catalytic activity, with its overall enzymatic performance remaining essentially unchanged. R2-2 showed a simultaneous decrease in both optimal temperature and catalytic activity, exhibiting a significant negative functional change. R2-3 had an optimal temperature of 72℃, which was 17℃ higher than that of WT, and its enzyme activity at 70℃ was equivalent to 130% of the maximum enzyme activity of WT. Then, the thermostability of WT, Mut14, and R2-3 was measured. Figure 3 Incubation at 50℃ to 70℃ for 30 min revealed that, compared to WT, Mut14 exhibited a sharp decrease in relative activity at all temperatures, while R2-3 showed higher thermal stability at moderate temperatures compared to WT. Therefore, R2-3 was selected and named Mut12 as the optimal combination mutant for subsequent experiments.

[0043] DNA sequence of mutant Mut12 (SEQ ID NO: 15): GCTACACCT CCTGACTGGAGAAGTCAATCCATCTACTTTCTGTTGACCGATAGATTCGCTAGAACTGATGGTTCCACTACCGCTACATGTAACACCGCTGATCAGAAGTATTGCGGTGGAACTTGGCAAGGCATCATCGACAAACTGGACTATATCCAAGGTATG GCT TTCACTGCTATCTGGATTACACCTGTTACTGCACAATTGCCTCAA ATC ACTGCTTATGGTGATGCTTATCATGGTTACTGGCAGCAAGACATCTACTCTCTGAATGAGAACTACGGTACTGCTGACGATCTGAAAGCCTTGTCTAGTGCCTTGCATGAAAGAGGTATGTATCTGATGGTTGATGTCGTTGCTAAT CGC ATGGGATACGATGGTGCTGGATCTTCTGTTGATTATAGTGTGTTCAAGCCTTTCTCTAGTCAAGATTATTTCCATCCATTCTGTTTCATCCAGAACTACGAGGATCAAACTCAAGTCGAAGATTGCTGGTTGGGAGATAATACCGTCTCTTTGCCAGACTTGGACACCACA AGG GATGTCGTTAAGAACGAATGGTACGATTGGGTTGGTTCACTGGTTTCCAATTACTCTATTGATGGACTGAGAATTGATACTGTCAAACATGTT CGG AAAGATTTCTGGCCTGGCTACAAC AGG GCTGCCGGTGTCTACTGTATTGGTGAAGTGTTGGATGGCGACCCTGCATACACTTGTCCATATCAGAACGTCATGGACGGAGTCTTGAACTATCCAATCTACTATCCATTGCTGAATGCTTTCAAG CTT ACTTCTGGCTCAATGGATGATCTGTACAACATGATC AGC ACCGTTAAGTCTGATTGTCCAGATTCCACTTTGTTGGGTACTTTCGTTGAGAACCATGACAATCCAAGATTC ACTTCTTACACTAATGACATCGCTCTGGCTAAGAACGTT GTT GCTTTCATCATCTTGAACGATGGTATTCCAATCATCTACGCTGGTCAAGAA CAC CATTATGCTGGTGGTAATGATCCAGCTAATAGAGAGGCTACTTGGCTGTCTGGTTATCCAACCGATTCTGAGCTGTAC The amino acid sequence of mutant Mut12 (SEQ ID NO: 16): ATPPDWRSQSIYFLLTDRFARTDGSTTATCNTADQKYCGGTWQGIIDKLDYIQGMAFTAIWITPVTAQLPQITAYGDAYHGYWQQDIYSLNENYGTADDLKALSSALHERGMYLMVDVVANRMGYDGAGSSVDYSVFKPFSSQDYFHPFCFIQNYEDQTQVEDCWLGDNTVSLPDLDTT RDVVKNEWYDWVGSLVSNYSIDGLRIDTVKHVRKDFWPGYNRAAGVYCIGEVLDGDPAYTCPYQNVMDGVLNYPIYYPLLNAFKLTSGSMDDLYNMISTVKSDCPDSTLLGTFVENHDNPRFTSYTNDIALAKNVVAFIILNDGIPIIYAGQEHHYAGGNDPANREATWLSGYPTDSELY Table 5 ΔΔ G and B-factor analysis

[0044] Note: In B-factor, red indicates high flexibility; white indicates medium flexibility; and blue indicates low flexibility.

[0045] Table 6 Spatial location analysis of site distances (only those <12 Å are listed)

[0046] Note: Site distance analysis: <8 Å (high risk); 8-12 Å (medium risk); >12 Å (low risk) Table 7 List of site-directed response mutation primers (underlined parts indicate mutation sites)

[0047] Example 6 The specific steps for the enzymatic property analysis of Mut12 are as follows: 1) Determination of optimal reaction temperature and optimal reaction pH Amylase activity was measured after incubation for 30 min at each temperature within the range of 30 to 90 °C. To determine the optimal pH, amylase activity was measured after incubation for 30 min at the optimal temperature in 50 mM citrate buffer (pH 3.0–4.0), 50 mM phosphate buffer (pH 5.0–8.0), 50 mM Tris-HCl buffer (pH 9.0), and 50 mM glycine-NaOH buffer (pH 10.0). Under optimal conditions, the relative activity of amylase was defined as 100%. Mut12 has an optimal pH of 5.5 and a relatively wide pH range. Figure 4 The optimal temperature of Mut12 was determined by measuring the temperature range of 30–90℃. The optimal temperature of Mut12 was 72℃. At 70℃ and 60℃, Mut12 retained 94% and 86% of its relative activity, respectively. Figure 4 ).

[0048] 2) Thermal stability determination The effect of temperature on the stability of Mut12 was determined. The enzyme was placed in a water bath at 40℃, 45℃, 50℃, 55℃, 60℃, 65℃, and 70℃ and incubated in 50mM phosphate buffer at pH 5.5. Samples were taken at different time points (0, 30, 60, 120, 240, 360, and 480 min). After sampling, the samples were immediately cooled on ice to terminate the heat treatment and the enzyme activity was measured. The enzyme activity of the untreated sample at 0 min was used as a control (defined as 100%), and the relative residual enzyme activity percentage of the samples at each time point was calculated. The thermostability was evaluated with the enzyme activity at 0 min as 100%. Figure 4 Within the 40°C to 50°C range, Mut12 exhibited strong stability: after incubation at 40°C and 45°C for 480 min, the residual activity remained at 99% and 98%, respectively; after incubation at 50°C for 480 min, the residual activity was approximately 69%. At 55°C, the stability of Mut12 gradually decreased, with the residual activity reaching approximately 86% after 120 min and decreasing to 53% after 480 min. At 60°C, the residual activities of Mut12 after incubation for 120 min and 240 min were 76% and 60%, respectively, and approximately 41% of the activity was retained after 480 min. At 65°C, the residual activities of Mut12 after incubation for 60 min and 120 min were 65% and 49%, respectively.

[0049] 3) Expression and purification Single colonies were picked and cultured on BMGY medium at 28°C and 200 rpm for 2 days. The bacterial cells were then centrifuged and the BMMY induction medium was replaced. 1% methanol was added daily for 5 days of fermentation. After fermentation, the supernatant was collected by centrifugation for 10 min at 4°C and 10,000 rpm for 10 min. The supernatant was concentrated using an ultrafiltration tube. The concentrated supernatant was dialyzed in pH 8.0 phosphate buffer at 4°C for 12 h, followed by centrifugation at 4°C and 10,000 rpm for 10 min. The supernatant sample was then collected. A QSepharose Fast Flow (QSFF) anion exchange chromatography column was then equilibrated with 20 mmol / L pH 8.0 phosphate buffer and loaded at a flow rate of 0.5 mL / min. The column was washed with the same buffer until the effluent showed a UV absorbance (OD) value of 280 nm. 280 The concentration was below 0.1. Elution was then performed using 20 mmol / L pH 8.0 phosphate buffer containing 150 mmol / L NaCl at a flow rate of 1.0 mL / min; further elution was performed using 20 mmol / L pH 8.0 phosphate buffer containing 250 mmol / L NaCl, and the enzymatically active eluent fraction was collected.

[0050] 4) Enzyme kinetic parameters The kinetic parameters of the purified enzyme were determined at different concentrations of soluble starch (0.5-20 mg / mL) under conditions of pH 6.0 and 50℃. The initial rate data were fitted to the Michaelis-Menten equation using nonlinear regression to obtain the kinetic constants using GraphPad Prism 9 software. The results are shown in Table 8. Compared with WT, the specific activity of Mut12 increased from 31.5 ± 0.8 U / mg to 38.00 ± 0.5 U / mg, an increase of approximately 20%. p <0.01. The Km value changed from 4.23±0.93 mg / mL to 4.38±1.0 mg / mL, but the difference was not statistically significant. p >0.05), indicating that the combined mutation did not significantly affect substrate affinity. The catalytic constant Kcat decreased from 11.76 ± 0.49 min. -1 Increased to 15.04±0.9 min -1 It increased by about 28% ( p The catalytic efficiency Kcat / Km increased from 2.78±0.5 mL / (min·mg) to 3.43±0.9 mL / (min·mg), an increase of approximately 23% (P<0.01).

[0051] Table 8. Kinetic parameters of WT and Mut12 enzymes

[0052] The dynamic parameters were calculated based on a minute timescale.

[0053] a: The data comes from three independent experiments, and "±" represents the standard deviation.

[0054] p <0.05, p <0.01, which is significantly different from WT.

[0055] 6) TLC hydrolysis characteristics analysis The hydrolytic characteristics of the enzyme were tested using thin-layer chromatography (TLC). Soluble starch (1%, w / v) and the purified enzyme were incubated in 50 mM phosphate buffer (pH 6.0) at 50 °C for 1 h. TLC conditions were as follows: a suitable amount of sample was spotted onto a silica gel plate, developed with a developing solvent (n-butanol:acetic acid:water, 4:1:1), and then the silica gel plate was completely wetted with a colorimetric reagent (methanol / sulfuric acid, 95:5). After drying, the plate was developed in a 130 °C oven. Analysis of the hydrolysis products is shown below. Figure 4 When incubated at 50°C for 1 hour, the hydrolysis products of soluble starch by Mut12 mainly consist of maltotriose, maltose, and a small amount of glucose, which are similar to the hydrolysis characteristics of WT.

[0056] Example 7: Application of Mut12 in corn starch hydrolysis Using corn starch as a substrate, the application performance of the α-amylase mutant Mut12 obtained in this invention during starch hydrolysis was evaluated. Corn starch was prepared into a starch suspension, gelatinized, and then purified Mut12 enzyme solution was added for hydrolysis. WT was used as a control, and comparisons were made under the same reaction conditions. During the reaction, the starch conversion efficiency was evaluated by detecting the reducing sugar content at different time points, and the composition of the hydrolysis products was analyzed by high-performance liquid chromatography.

[0057] Figure 5 This demonstrates the application performance of the mutant Mut12 in corn starch hydrolysis, from Figure 5 As can be seen from Figure a, under the condition of 60℃, WT has a high hydrolysis capacity in the early stage of the reaction, but the conversion rate tends to plateau (about 20%) after about 2 h and no longer increases significantly thereafter; while the conversion rate of Mut12 continues to rise, reaching about 40% at 8 h, showing a significantly improved sustained catalytic capacity. Figure 5Quantitative analysis of the products in Mut12 showed that with the extension of hydrolysis time, the relative proportion of small molecule sugars such as G1 (glucose), G2 (maltose), and G3 (maltotriose) in the hydrolysate gradually increased, while the proportion of larger molecule sugars (G4 and G5) decreased accordingly. This indicates that Mut12 can continuously hydrolyze starch into small molecule sugar products under high temperature conditions, and its hydrolysate composition pattern is similar to that of WT. This shows that the multi-site mutation did not change the basic catalytic characteristics of α-amylase, but significantly improved its application performance under high temperature conditions.

[0058] The above are all preferred embodiments of the present invention and are not intended to limit the scope of protection of the present invention. Therefore, all equivalent changes made in accordance with the structure, shape and principle of the present invention should be covered within the scope of protection of the present invention.

Claims

1. A mutant of Aspergillus oryzae α-amylase, characterized in that, The amino acid sequence of the mutant is shown in SEQ ID NO:

16.

2. The Aspergillus oryzae α-amylase mutant according to claim 1, characterized in that, The mutant is a truncated form of Aspergillus oryzae α-amylase as shown in SEQ ID NO:

8. Ao Based on the AmyB~1~ amino acid sequence, it contains the following 12 amino acid substitutions: alanine at position 4 is mutated to proline (A4P), glycine at position 56 is mutated to alanine (G56A), threonine at position 72 is mutated to isoleucine (T72I), histidine at position 122 is mutated to arginine (H122R), lysine at position 180 is mutated to arginine (K180R), glutamine at position 212 is mutated to arginine (Q212R), lysine at position 221 is mutated to arginine (K221R), serine at position 264 is mutated to leucine (S264L), asparagine at position 277 is mutated to serine (N277S), alanine at position 302 is mutated to threonine (A302T), alanine at position 315 is mutated to valine (A315V), and glutamine at position 333 is mutated to histidine (Q333H).

3. A DNA molecule encoding the Aspergillus oryzae α-amylase mutant of claim 1 or 2, characterized in that, The nucleotide sequence of the DNA molecule is shown in SEQ ID NO:

15.

4. A recombinant expression vector, characterized in that, The recombinant expression vector contains the DNA molecule as described in claim 3.

5. A method for constructing an α-amylase mutant of Aspergillus oryzae, characterized in that, Includes the following steps: (1) Using the truncated AoAmyB1 gene of Aspergillus oryzae α-amylase shown in SEQ ID NO:7 as a template, a random mutant library was constructed by error-prone PCR; (2) Perform high-throughput screening on the random mutant library obtained in step (1) to obtain positive clones with improved thermal stability; (3) Sequencing of positive clones to identify beneficial mutation sites; (4) Combine multiple beneficial mutation sites obtained from screening to construct a combined mutant; (5) Perform reverse mutation optimization on the combined mutants obtained in step (4) and screen to obtain mutants with improved thermal stability.

6. The construction method according to claim 5, characterized in that, The high-throughput screening in step (2) uses the residual enzyme activity after treatment at 68℃ for 30 min as the screening index.

7. The construction method according to claim 5, characterized in that, The combined mutant mentioned in step (4) is Mut14 containing 14 amino acid substitutions, namely: A4P, G56A, T72I, A120T, H122R, C150S, K180R, Q212R, K221R, S264L, N277S, A302T, A315V, and Q333H.

8. The construction method according to claim 5, characterized in that, The reverse mutation optimization described in step (5) includes: removing the A120T and C150S mutation sites from Mut14 to obtain Mut12 containing 12 amino acid substitutions.

9. The use of the Aspergillus oryzae α-amylase mutant according to claim 1 or 2 in starch hydrolysis or malt oligosaccharide preparation.